Cargando…
Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Nicotinamide riboside (NR) is a newly discovered nicotinamide adenine dinucleotide (NAD(+)) precursor vitamin. A crystal form of NR chloride termed NIAGEN is generally recognized as safe (GRAS) for use in foods and the subject of two New Dietary Ingredient Notifications for use in dietary supplement...
Autores principales: | Conze, Dietrich, Brenner, Charles, Kruger, Claire L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611812/ https://www.ncbi.nlm.nih.gov/pubmed/31278280 http://dx.doi.org/10.1038/s41598-019-46120-z |
Ejemplares similares
-
Dihydronicotinamide riboside: synthesis from nicotinamide riboside chloride, purification and stability studies
por: Zarei, Amin, et al.
Publicado: (2021) -
Synthesis, Stability, and Bioavailability of Nicotinamide Riboside Trioleate Chloride
por: Zarei, Amin, et al.
Publicado: (2021) -
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
por: Fletcher, Rachel S., et al.
Publicado: (2017) -
Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
por: Leung, Christopher Kai Shun, et al.
Publicado: (2022) -
Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
por: Leung, Christopher Kai Shun, et al.
Publicado: (2022)